[Studies on the abnormal response of pituitary somatotropin to dopaminergic drugs in patients with acromegaly]
- PMID: 2150352
[Studies on the abnormal response of pituitary somatotropin to dopaminergic drugs in patients with acromegaly]
Abstract
This article studies the effects of dopaminergic drugs on the pituitary GH secreting adenoma. The secretion of GH was enhanced and suppressed in 6 normal adults and 5 acromegalic patients respectively after intravenous infusion of dopamine and oral ingestion of L-dopa. Simultaneous administration of L-dopa and carbidopa (a drug that inhibits the conversion of L-dopa to dopamine in peripheral tissue) showed no suppressive or stimulatory effect on the secretion of GH in acromegaly. This result indicates that an abnormality in the GH secreting cell may be the cause of the different responses of GH to dopaminergic drugs in acromegaly.
Similar articles
-
In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.J Clin Endocrinol Metab. 1979 Nov;49(5):737-41. doi: 10.1210/jcem-49-5-737. J Clin Endocrinol Metab. 1979. PMID: 489713
-
Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.J Clin Endocrinol Metab. 1978 Sep;47(3):647-52. doi: 10.1210/jcem-47-3-647. J Clin Endocrinol Metab. 1978. PMID: 263317
-
Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.J Clin Invest. 1978 Apr;61(4):973-80. doi: 10.1172/JCI109022. J Clin Invest. 1978. PMID: 659585 Free PMC article.
-
Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.J Clin Invest. 1984 Jan;73(1):66-78. doi: 10.1172/JCI111208. J Clin Invest. 1984. PMID: 6140273 Free PMC article.
-
Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.J Clin Endocrinol Metab. 1987 Feb;64(2):255-60. doi: 10.1210/jcem-64-2-255. J Clin Endocrinol Metab. 1987. PMID: 3793848